World's Best Scientists 2026 revealed!
Wim Vanden Berghe

Wim Vanden Berghe

D-Index & Metrics

Biology and Biochemistry

D-Index
68
Citations
19847
World Ranking
7693
National Ranking
141

Overview

Wim Vanden Berghe is affiliated with the University of Antwerp in Belgium. Their research output spans multiple fields and subfields, primarily focusing on medicine, biochemistry, genetics, and molecular biology. The scientist's work is distributed across several specialized areas including molecular biology, epidemiology, immunology, complementary and alternative medicine, and physiology.

Their research encompasses a range of main topics, notably:

  • Epigenetics and DNA Methylation
  • Reproductive tract infections research
  • Syphilis Diagnosis and Treatment
  • Ferroptosis and cancer prognosis
  • RNA modifications and cancer
  • Liver Disease Diagnosis and Treatment
  • COVID-19 Clinical Research Studies

Frequent co-authors collaborating with Wim Vanden Berghe include:

  • Emilie Logie (13 publications)
  • Claudina Pérez-Novo (13 publications)
  • Ken Declerck (11 publications)
  • Andrea Orellana-Manzano (10 publications)
  • Claudio Peter D'Incal (9 publications)

Key venues where this scientist's research has been published frequently consist of:

  • bioRxiv (Cold Spring Harbor Laboratory) - 6 publications
  • Research Square (Research Square) - 5 publications
  • The FASEB Journal - 4 publications
  • Antioxidants - 3 publications
  • Clinical Epigenetics - 3 publications

Among recent papers authored or co-authored by Wim Vanden Berghe, the following stand out:

  • "Aging and chronic inflammation: highlights from a multidisciplinary workshop," 2023, Immunity & Ageing
  • "Nutrition and the ageing brain: Moving towards clinical applications," 2020, Ageing Research Reviews
  • "Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study," 2022, The Lancet Microbe
  • "SARS-CoV-2 and cancer: Are they really partners in crime?", 2020, Cancer Treatment Reviews
  • "In Vitro Anti-Inflammatory, Anti-Oxidant, and Cytotoxic Activities of Four Curcuma Species and the Isolation of Compounds from Curcuma aromatica Rhizome," 2020, Biomolecules

Best Publications

  • Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

    Philippe Delerive;Karolien De Bosscher;Sandrine Besnard;Wim Vanden Berghe

  • The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression

    Karolien De Bosscher;Wim Vanden Berghe;Guy Haegeman

  • Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1)

    Linda Vermeulen;Gert De Wilde;Petra Van Damme;Wim Vanden Berghe

  • p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways Are Required for Nuclear Factor-κB p65 Transactivation Mediated by Tumor Necrosis Factor

    Wim Vanden Berghe;Stéphane Plaisance;Elke Boone;Karolien De Bosscher

  • Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma

    Behrouz Hassannia;Bartosz Wiernicki;Irina Ingold;Feng Qu

  • How glucocorticoid receptors modulate the activity of other transcription factors: A scope beyond tethering

    Dariusz Ratman;Wim Vanden Berghe;Lien Dejager;Claude Libert

  • Glucocorticoid-mediated repression of nuclear factor-κBdependent transcription involves direct interference with transactivation

    Karolien De Bosscher;M. Lienhard Schmitz;Wim Vanden Berghe;Stéphane Plaisance

  • The Zinc Finger Protein A20 Inhibits TNF-induced NF-κB–dependent Gene Expression by Interfering with an RIP- or TRAF2-mediated Transactivation Signal and Directly Binds to a Novel NF-κB–inhibiting Protein ABIN

    Karen Heyninck;Dirk De Valck;Wim Vanden Berghe;Wim Van Criekinge

  • The Nuclear Factor-κB Engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter

    Wim Vanden Berghe;Karolien De Bosscher;Elke Boone;Stéphane Plaisance

  • Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell

    Karolien De Bosscher;Wim Vanden Berghe;Linda Vermeulen;Stéphane Plaisance

  • Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit

    Linda Vermeulen;Gert De Wilde;Sofie Notebaert;Wim Vanden Berghe

  • Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6.

    Wim Vanden Berghe;Linda Vermeulen;Gert De Wilde;Karolien De Bosscher

  • Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors

    Karolien De Bosscher;Wim Vanden Berghe;Guy Haegeman

  • Crosstalk in inflammation :The interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases

    Ilse M. E. Beck;Wim Vanden Berghe;Linda Vermeulen;Keith R. Yamamoto

  • Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.

    Mary Kaileh;Wim Vanden Berghe;Arne Heyerick;Julie Horion

  • Cross-talk between nuclear receptors and nuclear factor |[kappa]|B

    K De Bosscher;W Vanden Berghe;G Haegeman

  • A fully dissociated compound of plant origin for inflammatory gene repression

    Karolien De Bosscher;Wim Vanden Berghe;Ilse M. E. Beck;Wim Van Molle

  • Screening of indigenous Palestinian medicinal plants for potential anti-inflammatory and cytotoxic activity.

    Mary Kaileh;Wim Vanden Berghe;Elke Boone;Tamer Essawi

  • A paradigm for gene regulation: inflammation, NF-kappaB and PPAR.

    Wim Vanden Berghe;Linda Vermeulen;Philippe Delerive;Philippe Delerive;Karolien De Bosscher

  • N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition.

    Valérie Verhasselt;Wim Vanden Berghe;Nathalie Vanderheyde;Fabienne Willems

Frequent Co-Authors

Guy Haegeman
Guy Haegeman Ghent University
Karolien De Bosscher
Karolien De Bosscher Ghent University
Guy Van Camp
Guy Van Camp University of Antwerp
Greet Schoeters
Greet Schoeters University of Antwerp
Claude Libert
Claude Libert Ghent University
Christine Morand
Christine Morand University of Clermont Auvergne
Gudrun Koppen
Gudrun Koppen University of Antwerp
Tom Vanden Berghe
Tom Vanden Berghe University of Antwerp
Luc Pieters
Luc Pieters University of Antwerp
Bart Staels
Bart Staels University of Lille

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Wim Vanden Berghe

Trending Scientists

Recently Published Articles